1245 Impact of the National Cancer Research Network clinical trials portfolio at Guy's & St. Thomas' Hospital and peripheral trusts in SE London

2003 ◽  
Vol 1 (5) ◽  
pp. S379
Author(s):  
A. Quennell ◽  
M. Kent ◽  
A. Poole ◽  
H. McVicars ◽  
A. Shepherd
2020 ◽  
pp. ijgc-2020-001652
Author(s):  
William Small Jr ◽  
Gheorghe Peltecu ◽  
Anastasia Puiu ◽  
Andrei Corha ◽  
Elena Cocîrṭă ◽  
...  

Cervical cancer is the third most common cancer among women worldwide, with a disproportionately high burden of disease in less-developed regions of the world. The Cervix Cancer Research Network was founded by the Gynecologic Cancer InterGroup with a mission to improve outcomes in cervical cancer by enhancing international access to clinical trials, specifically in under-represented, underdeveloped areas. The Cervix Cancer Research Network held its third international educational symposium in Bucharest in 2018 and is the subject of this report. The purpose of this symposium was to advance the international understanding of cervical cancer treatment patterns, to foster recruitment to Cervix Cancer Research Network clinical trials, and identify key Cervix Cancer Research Network clinical trial concepts to improve cervical cancer care worldwide.


2020 ◽  
Vol 9 (6) ◽  
pp. 2146-2152
Author(s):  
Michael E. Roth ◽  
Joseph M. Unger ◽  
Ann M. O'Mara ◽  
Mark A. Lewis ◽  
Troy Budd ◽  
...  

2016 ◽  
Vol 26 (9) ◽  
pp. 1690-1693 ◽  
Author(s):  
David Gaffney ◽  
Bill Small ◽  
Henry Kitchener ◽  
Sang Young Ryu ◽  
Akila Viswanathan ◽  
...  

AbstractEighty-seven percent of cervix cancer occurs in less-developed regions of the world, and there is up to an 18-fold difference in mortality rate for cervix cancer depending on the region of the world. The Cervix Cancer Research Network (CCRN) was founded through the Gynecologic Cancer InterGroup with the aim of improving access to clinical trials in cervix cancer worldwide, and in so doing improving standards of care. The CCRN recently held its first international educational symposium in Bangkok. Sixty-two participants attended from 16 different countries including Pakistan, India, Bangladesh, Thailand, Malaysia, Singapore, Philippines, Taiwan, China, Vietnam, Korea, Japan, Columbia, Brazil, Canada, and the United States. The focus of this symposium was to evaluate progress, to promote new clinical trials for the CCRN, and to provide education regarding the role of brachytherapy in the treatment of cervical cancer.


2013 ◽  
Vol 11 (3) ◽  
pp. 128-128
Author(s):  
C. C. Johnson ◽  
C. Chao ◽  
L. Engel ◽  
H. Feigelson ◽  
J. Fortuny ◽  
...  

2017 ◽  
Vol 11 (12) ◽  
pp. 379-87 ◽  
Author(s):  
Jennifer Jones ◽  
Jaimin Bhatt ◽  
Jonathan Avery ◽  
Andreas Laupacis ◽  
Katherine Cowan ◽  
...  

It is critically important to define disease-specific research priorities to better allocate limited resources. There is growing recognition of the value of involving patients and caregivers, as well as expert clinicians in this process. To our knowledge, this has not been done this way for kidney cancer. Using the transparent and inclusive process established by the James Lind Alliance, the Kidney Cancer Research Network of Canada (KCRNC) sponsored a collaborative consensus-based priority-setting partnership (PSP) to identify research priorities in the management of kidney cancer. The final result was identification of 10 research priorities for kidney cancer, which are discussed in the context of current initiatives and gaps in knowledge. This process provided a systematic and effective way to collaboratively establish research priorities with patients, caregivers, and clinicians, and provides a valuable resource for researchers and funding agencies.


Lung Cancer ◽  
2017 ◽  
Vol 103 ◽  
pp. S76-S77
Author(s):  
S. Ajab ◽  
S.S.S. Begum ◽  
H. Stanley ◽  
S. Matthews ◽  
P.M. Fisher ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document